Belt and Road Summit 2025- Deal-making

10–16 Sept 2025 | China (Hong Kong)

Seungtaek NA

Managing Partner

Daejoong Life Science

Seoul, South Korea

8 profile visitsProject Owner

I am a managing partner of Daejoong Life Science, a financial advisory company and venture creation company.

My organisation

As a venture creation company, Daejoong Life Science set up a NewCo who would like to acquire the commercialization right of dosing completed US phase Ⅲ asset in the Great China region (China, Taiwan, Hong Kong & Macau)
Read more

About me

As a managing partner of Daejoong Life Science, a financial advisory company and venture creation company, we would like to acquire the commercialization right of US Phase Ⅲ OA(OsteoArthritis) Asset in the Greater China Region(China, Taiwan, Hong Kong and Macau), hopefully together with interested investors.

Social media

Marketplace (1)

  • Project

    Project for Potential Osteoarthritis Global Player

    Commercialization after Acquisition of US phase 3 dosing completed asset in the territory of "China, Taiwan, Hong Kong and Macau" at first.

    • Yes
    • None
    • Equity
    • Bio-Tech
    • Technology
    • Private Project
    • Project Planning
    • Financial Services
    • Interim Management
    • Open for Negotiation
    • Professional Services
    • 50,000,001 USD or above
    • 2,500,001 to 5,000,000 USD
    • Market Entry Strategic Analysis
    • Private Equity & Venture Capital
    Author

    Seungtaek NA

    Managing Partner at Daejoong Life Science

    Seoul, South Korea